Bharat Parenterals Ltd Share Price

Bharat Parenter.
Small Cap | Pharmaceuticals
₹ 1100 -62 (-5.34%)
Last updated: 05-Dec-2025 , 16:01:45

Bharat Parenterals Ltd Live Price Chart

Low: ₹1080.2 High: 1160

Bharat Parenterals Ltd Technicals

Current Price
₹ 1100 -62 (-5.34%)
EMASMA
20 Day ₹ 1,147.881
50 Day ₹ 1,197.526
100 Day ₹ 1,240.238
200 Day ₹ 1,259.848
20 Day ₹ 1,128.180
50 Day ₹ 1,200.931
100 Day ₹ 1,323.544
200 Day ₹ 1,202.235

Bharat Parenterals Ltd Performance

Previous Close ₹ 1162
High ₹ 1160
Volume 773
52W Range ₹ 802 - ₹ 1848.9
Open ₹ 1155
Low ₹ 1080.2
Market Cap 793.23 Cr

Bharat Parenterals Ltd Fundamentals

ROCE 8.248
P/E Ratio 37.230
P/B Ratio 2.010
Industry P/E 2.010
Debt to Equity 40.401
ROE 5.393
EPS 31.210
Dividend Yield 0.090
Book Value 578.778
Face Value 10.000

Bharat Parenterals Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 318.682 266.114 236.8199 219.7916 212.3372
Total Expenses 282.3668 235.3131 204.6506 191.4232 185.3182
Profit After Tax 26.4536 22.5936 24.3369 21.3036 20.2105

Bharat Parenterals Ltd Shareholding Pattern

Promoter Holdings 67.194 %
FIIs 0.109 %
DIIs 0.542 %
MutualFund 0.000 %
Retail 19.269 %
Others - 12.886 %

About Bharat Parenterals Ltd

History of Bharat Parenterals Ltd

Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016. Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020. Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022. ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Amrutanjan Health Care Ltd ₹ 544.1 - ₹ 842.9 659.9 33.96
Bliss GVS Pharma Ltd ₹ 108.12 - ₹ 190.97 170.1 22.5
Biofil Chemicals & Pharmaceuticals Ltd ₹ 32.6 - ₹ 68.53 34.9 19.43
Marksans Pharma Ltd ₹ 162 - ₹ 358.55 183.5 35.32
Syncom Formulations (India) Ltd ₹ 14.1 - ₹ 23.87 15.07 22.87

FAQs on Bharat Parenterals Ltd

1. Can I buy Bharat Parenterals Ltd from PL Capital? ›

Yes, you can invest in Bharat Parenterals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Bharat Parenterals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Bharat Parenterals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Bharat Parenterals Ltd pay dividends? ›

Yes, Bharat Parenterals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Bharat Parenterals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Bharat Parenterals Ltd ? ›

As of 04-12-2025 the share price for Bharat Parenterals Ltd. is 1162 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Bharat Parenterals Ltd ? ›

The 52-week high and low of Bharat Parenterals Ltd share price is ₹ 802 - ₹ 1848.9 as of 04-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source